STOCKHOLDERS’ EQUITY (Details Narrative)						3 Months Ended				9 Months Ended		12 Months Ended
	May 11, 2021 USD ($) $ / shares shares	Apr. 14, 2021 shares	Mar. 29, 2021 USD ($) $ / shares shares	Dec. 11, 2020 $ / shares shares	Jan. 09, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Dec. 31, 2020 $ / shares shares	Jul. 28, 2021 shares	Mar. 31, 2021 shares	Nov. 06, 2020 $ / shares shares	Jun. 18, 2020 shares	Dec. 31, 2019 shares	Dec. 31, 2017 shares
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized						200,000,000				200,000,000		200,000,000
Common stock, par value | $ / shares						$ 0.0001				$ 0.0001		$ 0.0001
Convertible redeemable series A preferred stock, shares authorized						50,000,000				50,000,000		50,000,000
Convertible redeemable series A preferred stock, par value | $ / shares						$ 0.0001				$ 0.0001		$ 0.0001
Proceeds from issuance of common stock | $	$ 25,400,000									$ 27,930,000
Stock option exercised shares							200,000			200,000
Net proceeds from exercise of options | $										$ 330,000
Offering cost | $										$ 2,200,000
Stock issued during period, shares, conversion of convertible securities											106,314
Number of shares for conversion of convertible debt, value | $									$ 796,069
Preferred stock shares outstanding						0				0		0
Preferred stock shares issued						0				0		0
Preferred stock series B, shares authorized						1,200,000				1,200,000		1,200,000
Preferred stock series B, par value | $ / shares						$ 0.0001				$ 0.0001		$ 0.0001
Weighted average remaining term										3 years 3 months 3 days	2 years 10 months 2 days
Warrants exercise price | $ / shares			$ 7.50
Fair value of warrants | $			$ 136,326
Share-based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Share-based compensation expense | $						$ 1,112,365	$ 428,663			$ 2,194,709	$ 1,345,931
Unrecognized expense | $						$ 5,623,852				$ 5,623,852
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		5,000	25,000
Warrant [Member] | Myo Correct Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase														95,000
Warrant [Member] | Myo Correct Agreement [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase														200,000
Warrant [Member] | Asset Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase			25,000
Warrant One [Member]
Subsidiary, Sale of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		10,000
Warrant Two [Member]
Subsidiary, Sale of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		10,000
Settlement Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase	276,000														325,000
Warrants exercise price | $ / shares															$ 7.50
Warrants expiration		Apr. 14, 2023													May 06, 2024
Fair value of warrants | $	$ 1,486,451
Settlement Warrants [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants expiration	May 11, 2026
Settlement Warrants [Member] | Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants expiration	Nov. 07, 2021
Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock price | $ / shares					$ 15.00
Gross proceeds from sale of stock | $					$ 15,000,000
Series B Preferred Stock [Member] | Contingent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price percentage					125.00%
Maxim Group LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of common stock | $											$ 0
Number of shares issued							0
Offering Costs [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued							2,000			4,800,000	166,648
Stock option exercised shares											25,000
Number of shares for conversion of convertible debt, value | $											$ 796,069
Conversion Price | $ / shares							$ 7.50				$ 7.50
Follow On Offering Costs [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued										4,600,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued				4,025,000
Sale of stock price | $ / shares				$ 6.00
IPO [Member] | Contingent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price | $ / shares	$ 6.00
IPO [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price | $ / shares												$ 8.90
Warrants expiration												Apr. 14, 2022
IPO [Member] | Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Debt instrument shares converted	1,199,195
Share price | $ / shares						$ 7.50				$ 7.50
IPO [Member] | Series B Preferred Stock [Member] | 2019 Notes [Member]
Subsidiary, Sale of Stock [Line Items]
Debt instrument shares converted												1,199,195
Board of Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued										50,000,000
Preferred stock series B, shares authorized					1,200,000
Preferred stock series B, par value | $ / shares					$ 0.0001
Share issuance price | $ / shares					$ 15.00
Board of Directors [Member] | Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of Stock, Amount Converted | $					$ 15.0
Conversion price percentage					0.75
Consultant [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued for services						0				2,667
Proceeds from issuance of common stock | $										$ 20,000
Consultants [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from convertible debt | $							$ 15,000				$ 1,248,569
Shareholder [Member]
Subsidiary, Sale of Stock [Line Items]
Shares reserved for future issuance												1,199,195
Shareholder [Member] | 2017 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Shares reserved for future issuance																		1,333,333
Shareholder [Member] | 2019 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Shares reserved for future issuance																	333,334
Common stock available for issuance shares													2,366,667			1,166,667
Shareholder [Member] | Restatement of 2019 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock available for issuance shares													1,200,000			833,333